Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sirot

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|October 1, 1994
Sequences of CAZ-3 and CTX-2 extended-spectrum beta-lactamase genesC Chanal, D Sirot, H Malaure, et al.
The Journal of Antimicrobial Chemotherapy|April 5, 2000
Clinical relevance of Proteus mirabilis in hospital patients: a two year surveyC de Champs, R Bonnet, D Sirot, et al.
Pathologie-Biologie|September 1, 1990
[Piperacillin-amikacin combinations: killing curves]M Chanal, J Sirot, C Chanal, et al.
Farmaco (Societa Chimica Italiana : 1989)|October 22, 2005
Syntheses, in vitro antibacterial and antifungal activities of a series of N-alkyl, 1,4-dithiinesF Zentz, R Labia, D Sirot, et al.
Journal of Clinical Microbiology|June 1, 1997
Relationship between adhesion to intestinal Caco-2 cells and multidrug resistance in Klebsiella pneumoniae clinical isolatesP Di Martino, D Sirot, B Joly, et al.
Reviews of Infectious Diseases|July 1, 1988
Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studiesJ Sirot, C Chanal, A Petit, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1994
Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitorsD Sirot, C Chanal, C Henquell, et al.
Infection and Immunity|June 1, 1996
A new fimbrial antigen harbored by CAZ-5/SHV-4-producing Klebsiella pneumoniae strains involved in nosocomial infectionsP Di Martino, V Livrelli, D Sirot, et al.
Pathologie-Biologie|May 1, 1986
[In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values]M Chanal, M Cluzel, D Sirot, et al.
Reviews of Infectious Diseases|July 1, 1988
Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporinsR Labia, A Morand, K Tiwari, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|October 1, 1994
Sequences of CAZ-3 and CTX-2 extended-spectrum beta-lactamase genesC Chanal, D Sirot, H Malaure, et al.
The Journal of Antimicrobial Chemotherapy|April 5, 2000
Clinical relevance of Proteus mirabilis in hospital patients: a two year surveyC de Champs, R Bonnet, D Sirot, et al.
Pathologie-Biologie|September 1, 1990
[Piperacillin-amikacin combinations: killing curves]M Chanal, J Sirot, C Chanal, et al.
Farmaco (Societa Chimica Italiana : 1989)|October 22, 2005
Syntheses, in vitro antibacterial and antifungal activities of a series of N-alkyl, 1,4-dithiinesF Zentz, R Labia, D Sirot, et al.
Journal of Clinical Microbiology|June 1, 1997
Relationship between adhesion to intestinal Caco-2 cells and multidrug resistance in Klebsiella pneumoniae clinical isolatesP Di Martino, D Sirot, B Joly, et al.
Reviews of Infectious Diseases|July 1, 1988
Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studiesJ Sirot, C Chanal, A Petit, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1994
Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitorsD Sirot, C Chanal, C Henquell, et al.
Infection and Immunity|June 1, 1996
A new fimbrial antigen harbored by CAZ-5/SHV-4-producing Klebsiella pneumoniae strains involved in nosocomial infectionsP Di Martino, V Livrelli, D Sirot, et al.
Pathologie-Biologie|May 1, 1986
[In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values]M Chanal, M Cluzel, D Sirot, et al.
Reviews of Infectious Diseases|July 1, 1988
Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporinsR Labia, A Morand, K Tiwari, et al.
Pageof 10